\Flexible Dosing: Clinically meaningful weight loss achieved even below maximum dosing levels
Thyroid tumors: Some GLP-1 medications carry a warning about a potential risk of thyroid C-cell tumors
After PSM, 81,152 participants remained in the SGLT2i group, and 20,288 participants remained in the GLP1RA group (Fig
Whats more, in vitro study results suggest Akkermansia may play a role in supporting GLP-1 by increasing secretion of an essential GLP-1 precursor.[1] And gut bacteria like Akkermansia can even play a role in the foods you crave
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: A prespecified analysis of the SELECT trial
Clinical trials have consistently shown that patients treated with semaglutide GLP-1 experience significant weight loss compared to those receiving a placebo, often exceeding the results achieved with other anti-obesity medications